Progesterone Receptor-negative Breast Cancer Completed Phase 2 Trials for Medroxyprogesterone acetate (DB00603)

IndicationStatusPhase
DBCOND0028547 (Progesterone Receptor-negative Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00577122Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast CancerTreatment